Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | ||
---|---|---|---|---|---|
1 | 2 | 3 | |||
Rash | very rare | x | x | x | |
Hypersensitivity | very rare | x | x | x | |
Hypertrichosis | very rare | x | x | x | |
Opportunistic infection | very rare | x | x | ||
Pruritus | very rare | x | x | ||
Erythema | very rare | x | x | x | |
Urticaria | very rare | x | x | ||
Skin atrophy | very rare | x | x | x | |
Allergic contact dermatitis | very rare | x | x | ||
Infection | x | x | |||
Contusion | x | ||||
Endocrine disorder | x | x | |||
Glaucoma | x | x | |||
Glycosuria | x | x | |||
Hair disorder | x | ||||
Hyperglycaemia | x | x | |||
Hypertension | x | x | |||
Immune system disorder | x | x | |||
Obesity | x | x | |||
Osteoporosis | x | x | |||
Rosacea | x | ||||
Telangiectasia | x | x | |||
Weight increased | x | x | |||
Cataract | x | x | |||
Growth retardation | x | x | |||
Skin striae | x | ||||
Unspecified disorder of skin and subcutaneous tissue | x | x | |||
Secondary adrenocortical insufficiency | x | ||||
Central obesity | x | x | |||
Cushingoid | x | x | |||
Atrophy | x | ||||
Secondary infection | x | ||||
Infestation NOS | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |